Gen-Probe blood assay gets FDA approval for hepatitis B
Gen-Probe has obtained expanded FDA clearance to use its Procleix Ultrio assay in screening donated blood for the hepatitis B virus. The agency previously approved the assay for use in examining donated blood for HIV-1 and the hepatitis C virus. Gen-Probe said the expanded approval will allow it to receive a milestone payment of $10 million from Chiron.
Pharmaceutical Business Review Online | 08/14
This story published in AABB SmartBrief on 08/15/2008
More from SmartBrief:
FDA clears midstage-trial design for Anadys' hepatitis C drug
Friday, July 31, 2009
Vertex secures $155M from debt financing for telaprevir
Friday, October 2, 2009
Baby had 11 transfusions while still in womb
Friday, September 4, 2009
Get stories like these delivered daily for FREE:
|
AABB SmartBrief
Designed specifically for the transfusion medicine and cellular therapy community, AABB SmartBrief is a FREE, daily e-mail newsletter. It provides a summary of the most important news in our field to members of AABB and beyond. To save time and stay smart, sign up today to receive AABB SmartBrief, free of charge. Learn more |
|